Form 4 Tracker
Louise Frederika Kooij

Chief Accounting Officer · 5 filings · Latest: Jul 20, 2026

NewAmsterdam Pharma Co N.V.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
NAMS
Kooij Louise FrederikaMar 4, 2025
Proposed Sale
$20.27150,000$3.0M
NAMS
Kooij Louise FrederikaOct 1, 2024
Proposed Sale
$17.2945,000$778.0K

← Previous

Page 2 of 2